Since extensive studies on human NAT genotype and phenotype have revealed a close relationship between NATs and different pathological conditions, such as cancer, looking for selective inhibitors of NAT enzymes in both humans and animal models has constituted a valuable tool to develop possible chemopreventive agents21. The gene discussed is BRD2; the disease is cancer.